Revolution Medicines (RVMD) Competitors $57.07 +0.60 (+1.06%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends RVMD vs. MRTX, KYMR, BNTX, TEVA, BGNE, VTRS, SMMT, MRNA, GMAB, and RDYShould you be buying Revolution Medicines stock or one of its competitors? The main competitors of Revolution Medicines include Mirati Therapeutics (MRTX), Kymera Therapeutics (KYMR), BioNTech (BNTX), Teva Pharmaceutical Industries (TEVA), BeiGene (BGNE), Viatris (VTRS), Summit Therapeutics (SMMT), Moderna (MRNA), Genmab A/S (GMAB), and Dr. Reddy's Laboratories (RDY). These companies are all part of the "medical" sector. Revolution Medicines vs. Mirati Therapeutics Kymera Therapeutics BioNTech Teva Pharmaceutical Industries BeiGene Viatris Summit Therapeutics Moderna Genmab A/S Dr. Reddy's Laboratories Mirati Therapeutics (NASDAQ:MRTX) and Revolution Medicines (NASDAQ:RVMD) are both mid-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, media sentiment, community ranking, profitability, institutional ownership, earnings and valuation. Do analysts prefer MRTX or RVMD? Mirati Therapeutics currently has a consensus price target of $59.00, suggesting a potential upside of 0.51%. Revolution Medicines has a consensus price target of $61.00, suggesting a potential upside of 6.89%. Given Revolution Medicines' stronger consensus rating and higher probable upside, analysts clearly believe Revolution Medicines is more favorable than Mirati Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mirati Therapeutics 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Revolution Medicines 0 Sell rating(s) 0 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 3.08 Do institutionals and insiders believe in MRTX or RVMD? 94.3% of Revolution Medicines shares are held by institutional investors. 3.3% of Mirati Therapeutics shares are held by insiders. Comparatively, 8.0% of Revolution Medicines shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has preferable valuation & earnings, MRTX or RVMD? Revolution Medicines has lower revenue, but higher earnings than Mirati Therapeutics. Revolution Medicines is trading at a lower price-to-earnings ratio than Mirati Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMirati Therapeutics$12.44M331.01-$740.87M-$12.22-4.80Revolution Medicines$11.58M829.04-$436.37M-$3.59-15.90 Does the media prefer MRTX or RVMD? In the previous week, Revolution Medicines had 5 more articles in the media than Mirati Therapeutics. MarketBeat recorded 5 mentions for Revolution Medicines and 0 mentions for Mirati Therapeutics. Mirati Therapeutics' average media sentiment score of 0.00 beat Revolution Medicines' score of -0.05 indicating that Mirati Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Mirati Therapeutics Neutral Revolution Medicines Neutral Which has more risk and volatility, MRTX or RVMD? Mirati Therapeutics has a beta of 0.77, indicating that its stock price is 23% less volatile than the S&P 500. Comparatively, Revolution Medicines has a beta of 1.4, indicating that its stock price is 40% more volatile than the S&P 500. Is MRTX or RVMD more profitable? Revolution Medicines has a net margin of 0.00% compared to Mirati Therapeutics' net margin of -1,900.65%. Revolution Medicines' return on equity of -33.67% beat Mirati Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Mirati Therapeutics-1,900.65% -82.15% -67.82% Revolution Medicines N/A -33.67%-30.08% Does the MarketBeat Community favor MRTX or RVMD? Mirati Therapeutics received 372 more outperform votes than Revolution Medicines when rated by MarketBeat users. However, 74.56% of users gave Revolution Medicines an outperform vote while only 62.86% of users gave Mirati Therapeutics an outperform vote. CompanyUnderperformOutperformMirati TherapeuticsOutperform Votes45762.86% Underperform Votes27037.14% Revolution MedicinesOutperform Votes8574.56% Underperform Votes2925.44% SummaryRevolution Medicines beats Mirati Therapeutics on 15 of the 19 factors compared between the two stocks. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Get Revolution Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for RVMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RVMD vs. The Competition Export to ExcelMetricRevolution MedicinesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.50B$2.93B$5.07B$8.90BDividend YieldN/A1.91%4.99%4.07%P/E Ratio-15.9016.1687.8613.46Price / Sales829.04282.771,228.8287.66Price / CashN/A169.3839.5136.27Price / Book6.134.436.946.30Net Income-$436.37M-$41.63M$119.12M$225.93M7 Day Performance-0.52%-4.73%-1.84%-1.32%1 Month Performance19.52%-6.53%-3.65%0.60%1 Year Performance174.51%25.63%31.64%26.23% Revolution Medicines Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RVMDRevolution Medicines2.7869 of 5 stars$57.07+1.1%$61.00+6.9%+162.6%$9.50B$11.58M-15.90443MRTXMirati Therapeutics0.5607 of 5 stars$58.70flat$59.00+0.5%N/A$4.12B$12.44M-4.80587Analyst ForecastKYMRKymera Therapeutics1.4071 of 5 stars$44.05+2.8%$52.13+18.4%+110.9%$2.77B$78.59M0.00170Analyst ForecastBNTXBioNTech3.4725 of 5 stars$102.14-4.0%$138.79+35.9%+3.3%$25.51B$4.13B0.006,133Analyst ForecastAnalyst RevisionTEVATeva Pharmaceutical Industries2.6924 of 5 stars$17.03+1.2%$19.67+15.5%+80.0%$19.04B$15.85B-20.0337,851BGNEBeiGene3.1891 of 5 stars$194.26+3.5%$247.07+27.2%+3.4%$18.29B$2.46B-23.5810,600Analyst DowngradeGap UpVTRSViatris1.3448 of 5 stars$13.13+0.6%$13.33+1.5%+38.6%$15.58B$15.43B0.0038,000SMMTSummit Therapeutics1.8653 of 5 stars$18.62-6.9%$34.75+86.6%+835.7%$14.75B$700,000.00-66.50105Analyst ForecastMRNAModerna4.6286 of 5 stars$36.94-0.9%$84.00+127.4%-53.2%$14.35B$6.85B-6.355,600Analyst UpgradeAnalyst RevisionGMABGenmab A/S4.3073 of 5 stars$20.45-0.2%$45.20+121.0%-37.0%$13.57B$2.39B19.852,204RDYDr. Reddy's Laboratories1.3294 of 5 stars$14.30-0.3%$17.00+18.9%+5.9%$11.98B$3.35B22.8427,048 Related Companies and Tools Related Companies MRTX Alternatives KYMR Alternatives BNTX Alternatives TEVA Alternatives BGNE Alternatives VTRS Alternatives SMMT Alternatives MRNA Alternatives GMAB Alternatives RDY Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:RVMD) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revolution Medicines, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revolution Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
